Our Glasgow meeting is almost upon us, we have over 400 registrants already and our events are reaching capacity too so I would encourage you to register now if you have not done so already. The programme looks great and there is even a fun run so you will effectively be attending a health farm while having your mind expanded in all areas of nuclear medicine!
 
Lu177 PSMA has been given compassionate use approval – there are links on the BNMS website giving the details of this. Great news for our specialty and the prequal to the likely full NICE approval expected in the Autumn. The likely rate limiting step initially will be access to diagnostic PSMA scans. We all need to be doing what we can to build capacity in this regard so that men with prostate carcinoma can have access to the correct treatment.
 
The BNMS is going to establish a visiting professor role for radiologists and nuclear medicine physicians to raise the profile of our discipline to radiology trainees to encourage them to follow our path. All radiology subspecialities are short of trainees now so we need to do everything we can to encourage trainees that nuclear medicine/radionuclide radiology is where they should land. We have much to offer for a future career.
 
Diagnostic waiting times are still a problem in the UK with PET-CT services still struggling to deliver the expected SLAs. I would like to thank you all for your hard work in providing PET-CT capacity. PET-CT is ever more important, particularly in cancer pathways, while this is good for our services it is hard to deliver against the demand. We need to plan for the continued expansion of this vital modality.
 
I look forward to seeing as many of you as I can in person in Glasgow. It will be a BNMS meeting to remember!

Prof Richard Graham

BNMS President